Preclinical Evaluation and Advancements in Vascularized Bone Tissue Engineering
Biomimetics · 20.06.2025 · 10 (7) · 412
DOI: 10.3390/biomimetics10070412 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomimetics, online erschienen am 20.06.2025. Verfasst von Toshiyuki Kawai. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Large segmental bone defects present significant challenges due to the insufficient vascularization of implanted grafts, necessitating advances in vascularized bone tissue engineering. Recent innovations focus primarily on enhancing graft vascularization through advanced biomaterial scaffolds, precise three-dimensional (3D) bioprinting technologies, biochemical interventions, and co-culture techniques. Biomaterial scaffolds featuring microchannels and high-surface-area architectures facilitate endothelial cell infiltration and subsequent vessel formation. Concurrently, sophisticated 3D-bioprinting methods, including inkjet, extrusion, and laser-assisted approaches, enable the precise placement of endothelial and osteogenic cells, promoting anatomically accurate vascular networks. Biochemical strategies that utilize the simultaneous delivery of angiogenic factors (e.g., vascular endothelial growth factor) and osteogenic factors (e.g., bone morphogenetic protein-2) effectively couple angiogenesis and osteogenesis. Additionally, co-culturing mesenchymal stem cells and endothelial progenitors accelerates the development of functional capillary networks. Preclinical studies consistently demonstrate superior outcomes for prevascularized grafts, as evidenced by enhanced vascular inosculation, increased bone formation, and improved mechanical stability compared to non-vascularized controls. These technological advancements collectively represent significant progress toward the clinical translation of engineered vascularized bone grafts capable of addressing complex and previously intractable bone defects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
ORCID-Profile: Toshiyuki Kawai
Zitieren
APA
Kawai, T. (2025). Preclinical Evaluation and Advancements in Vascularized Bone Tissue Engineering. Biomimetics, 10(7), 412. https://doi.org/10.3390/biomimetics10070412
Vancouver
Kawai T. Preclinical Evaluation and Advancements in Vascularized Bone Tissue Engineering. Biomimetics. 2025;10(7):412. doi:10.3390/biomimetics10070412
BibTeX
@article{Kawai2025,
author = {Kawai, Toshiyuki},
title = {Preclinical Evaluation and Advancements in Vascularized Bone Tissue Engineering},
journal = {Biomimetics},
year = {2025},
volume = {10},
number = {7},
pages = {412},
doi = {10.3390/biomimetics10070412}
}
EUVIMED